Related Experiment Videos
Nuclear destruction: A suicide mission by AKIRIN2 brings intact proteasomes into the nucleus
1Protein Processing Section, Center for Structural Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD 21702, USA.
Molecular Cell
|January 7, 2022
Abstract:
de Almeida et al. (2021) developed a temporally controlled CRISPR-Cas9 screen to identify mechanisms controlling MYC levels and discovered that intact proteasomes are imported into the nucleus by AKIRIN2 binding to proteasomes at one end and a nuclear import receptor at the other.
Insights
Researchers used CRISPR-Cas9 screening to find how MYC levels are controlled. They discovered AKIRIN2 imports intact proteasomes into the nucleus by linking them to nuclear import receptors.
Area of Science:
- Molecular Biology
- Cell Biology
- Genetics
Background:
- MYC protein levels are critical in cell growth and cancer.
- Understanding MYC regulation is key for developing targeted therapies.
Purpose of the Study:
- To identify novel mechanisms regulating MYC levels.
- To elucidate the role of proteasome nuclear import in MYC regulation.
Main Methods:
- Utilized a temporally controlled CRISPR-Cas9 screening approach.
- Investigated protein-protein interactions involved in nuclear transport.
Main Results:
- Identified AKIRIN2 as a crucial factor in proteasome nuclear import.
- Demonstrated that AKIRIN2 bridges intact proteasomes and nuclear import receptors.
- Linked this import mechanism to the control of MYC levels.
Conclusions:
- AKIRIN2-mediated nuclear import of proteasomes is a novel regulatory pathway for MYC.
- This finding offers new insights into cancer mechanisms and potential therapeutic targets.